The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
828
Drug F2695 SR (flexible dose) to be given orally in capsule form once daily
Adverse events, clinical laboratory tests, vital sign measurements, electrocardiograms, physical examinations, Columbia-Suicide Severity Rating Scale
Time frame: 48 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Forest Investigative Site 55
Dothan, Alabama, United States
Forest Investigative Site 29
Scottsdale, Arizona, United States
Forest Investigative Site 31
Beverly Hills, California, United States
Forest Investigative Site 3
Costa Mesa, California, United States
Forest Investigative Site 12
Encino, California, United States
Forest Investigative Site 6
Escondido, California, United States
Forest Investigative Site 22
Oceanside, California, United States
Forest Investigative Site 38
Sherman Oaks, California, United States
Forest Investigative Site 36
Denver, Colorado, United States
Forest Investigative Site 28
Denver, Colorado, United States
...and 58 more locations